WO2012134731A1 - Curable composition, article, method of curing, and reaction product - Google Patents

Curable composition, article, method of curing, and reaction product Download PDF

Info

Publication number
WO2012134731A1
WO2012134731A1 PCT/US2012/027816 US2012027816W WO2012134731A1 WO 2012134731 A1 WO2012134731 A1 WO 2012134731A1 US 2012027816 W US2012027816 W US 2012027816W WO 2012134731 A1 WO2012134731 A1 WO 2012134731A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
curable composition
carbon atoms
formula
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/027816
Other languages
English (en)
French (fr)
Inventor
Ilya Gorodisher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority to JP2014502591A priority Critical patent/JP5972353B2/ja
Priority to CN201280012964.7A priority patent/CN103562317A/zh
Priority to US14/003,121 priority patent/US20140011052A1/en
Priority to EP12709760.8A priority patent/EP2691466B1/en
Priority to KR1020137028015A priority patent/KR20140021613A/ko
Publication of WO2012134731A1 publication Critical patent/WO2012134731A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/02Polyamines
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/06Solidifying liquids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/59Arsenic- or antimony-containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/16Halogen-containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds

Definitions

  • 3-substituted-3,4-dihydro-2 /-l,3-benzoxazines are compounds containing the following structural unit: wherein R represents a monovalent organic group. In many cases, they are further substituted at one or more of the ring carbons. In those cases wherein R contains one or more aromatic groups, the 3- substituted benzoxazines may be highly viscous or even solid under ambient conditions. 3 -Substituted benzoxazines typically homopolymerize at elevated temperature.
  • U.S. Patent No. 4,501,864 reports a curable composition comprising a poly(3,4- dihydro-3-substituted-l,3 benzoxazine) and a reactive polyamine, wherein the polyamine is at least difunctional and its reactive groups are primary or secondary amine, and wherein the
  • poly(dihydrobenzoxazine) is the reaction product of about one equivalent of a primary amine, about one equivalent of a phenol and about two equivalents of formaldehyde.
  • thermosetting composition comprising (a) 97.9 to 40 percent by weight of at least one bis(dihydrobenzoxazine) prepared by the reaction of an unsubstituted or substituted bisphenol with at least one unsubstituted position ortho to each hydroxyl group, formaldehyde and a primary amine; (b) 2 to 50 percent by weight of at least one organic polyamine; and (c) 0.1 to 10 percent by weight of at least one curing catalyst, selected from the group of carboxylic acids, sulfonic acids and phosphonic acids having at least two acid groups and no other reactive groups; wherein the percent by weight refer to the total amount of components (a), (b) and (c) in the composition, with the proviso that (a), (b) and (c) add up to 100 percent by weight; and (d) and optionally other components.
  • the present disclosure provides a curable composition comprising:
  • R 1 represents an aryl group or a substituted aryl group
  • R 2 , R 3 , R 4 , and R 5 taken alone or in combination, represent H, halogen, a
  • hydrocarbyl group or a heterohydrocarbyl group
  • R 6 represents H, or a hydrocarbyl group
  • Z is an n-valent organic radical, wherein each of the -NH 2 groups is bonded to a tetraco ordinate carbon atom, wherein n is an integer greater than or equal to 1 , and wherein w/x is in a range of from 0.8 to 10;
  • the present disclosure provides a method, the method comprising at least partially curing a curable composition according to the present disclosure.
  • the present disclosure provides an article comprising a curable composition according to the present disclosure disposed on a releasable liner.
  • curable compositions including superacid catalyst according to the present disclosure can be effectively cured at lower temperatures than possible using previously disclosed acid catalysts.
  • FIG. 1 is a schematic cross sectional view of an exemplary article 100 according to the present disclosure
  • FIG. 2 is a plot showing heat flow versus temperature as measured by Differential Scanning Calorimetry for various curable compositions reported in the Examples.
  • FIG. 3 is a plot showing heat flow versus temperature as measured by Differential Scanning Calorimetry for various curable compositions reported in the Examples. It should be understood that numerous other modifications and embodiments can be devised by those skilled in the art, which fall within the scope and spirit of the principles of the disclosure.
  • the figures may not be drawn to scale. Like reference numbers may have been used throughout the figures to denote like parts.
  • heteroalkyl refers to alkyl wherein one or more heteroatoms independently selected from S, O, and N are substituted for carbon. Examples include, methoxy, ethoxy, propoxy, 3,6-dioxaheptyl, and 4-dimethylaminobutyl.
  • heteroaryl refers to aryl wherein one or more heteroatoms independently selected from S, O, and N are substituted for carbon. Examples include pyridyl, furanyl, pyrrolyl, thienyl, thiazolyl, oxazolyl, imidazolyl, indolyl, benzofuranyl, and benzthiazolyl.
  • hydrocarbyl refers to a hydrocarbon wherein one hydrogen atom has been removed. Examples include phenyl, butyl, methyl, dodecyl, behenyl, ethyl phenyl, and
  • heterohydrocarbyl refers to hydrocarbyl wherein one or more heteroatoms independently selected from S, O, and N are substituted for carbon. Examples include methoxy, ethoxy, propoxy, 4-diphenylaminobutyl, 2-(2'-phenoxyethoxy)ethyl, 3,6-dioxaheptyl, and 3,6- dioxahexyl-6-phenyl.
  • Curable compositions according to the present disclosure include at least one 3 -aryl benzoxazine.
  • 3 -Aryl benzoxazines are typically prepared by the condensation of a phenol, a primary arylamine, and an aliphatic aldehyde (typically formaldehyde); for example, according to long-established methods, although other aldehydes (e.g., alicyclic aldehydes or alkaryl aldehydes) may also be used.
  • an aliphatic aldehyde typically formaldehyde
  • aldehydes e.g., alicyclic aldehydes or alkaryl aldehydes
  • 3-Substituted benzoxazines may have additional substituents.
  • additional substituents for example, in some
  • the 3 -substituted benzoxazine ma be represented by the formula
  • R 1 represents an aryl or substituted aryl group having from 1 to 20 carbon atoms. In some embodiments, R 1 has from 1 to 20 carbon atoms or even from 1 to 8 carbon atoms. Examples include phenyl, methoxyphenyl, methylphenyl, chlorophenyl, 1 -naphthyl, and 4-methyl-2-pyridyl.
  • R 2 , R 3 , R 4 , and R 5 taken alone or in combination, independently represent H, halogen (e.g., Br, CI, F), a hydrocarbyl group having from 1 to 12 carbon atoms, or a heterohydrocarbyl group having from 1 to 12 carbon atoms.
  • R 2 -R 5 may independently represent alkyl (e.g., methyl, ethyl, propyl, hexyl, ethylhexyl, or octyl), aryl (e.g., phenyl, naphthyl, or phenanthryl), aralkyl (e.g., phenylethyl or benzyl), or alkaryl (e.g., ethylphenyl, dimethylphenyl, or methylphenyl), heteroalkyl (e.g., methoxy, methoxyethyl, thioethyl, dimethylamino, diethylamino, ethoxy, propoxy, 3,6-dioxaheptyl, or 4- dimethylaminobutyl), heteroaryl (e.g., pyridyl, furanyl, pyrrolyl, thienyl, thiazolyl,
  • R 6 represents H, or a hydrocarbyl group having from 1 to 12 carbon atoms. Examples include (e.g., methyl, ethyl, propyl, hexyl, ethylhexyl, or octyl), aryl (e.g., phenyl, or naphthyl), aralkyl (e.g., phenylethyl or benzyl), or alkaryl (e.g., ethylphenyl, dimethylphenyl, or methylphenyl).
  • aryl e.g., phenyl, or naphthyl
  • aralkyl e.g., phenylethyl or benzyl
  • alkaryl e.g., ethylphenyl, dimethylphenyl, or methylphenyl.
  • difunctional arylamines i.e., amines with two aminoaryl groups
  • compounds having two benzoxazine moieties are obtained; for example, as shown below wherein Z represents a divalent organic group having from 1 to 50 carbon atoms, and wherein Z is bonded to adjacent N atoms through aromatic carbon atom to nitrogen atom bonds.
  • 3-substituted benzoxazines may be represented by the formula
  • R 2 - R 6 are as previously defined, and R 7 represents a divalent organic group having from 1 to 50 carbon atoms, wherein terminal carbon atoms are aromatic carbon atoms.
  • R 7 include arylene (e.g., phenylene, biphenylene), -C H 6 CH 2 C H 6 -,
  • Useful commercially available 3-substituted benzoxazines include those available under the trade designation ARALDITE MT from Huntsman Corp. LLC (Salt Lake City, Utah). Examples include:
  • polyarylamines i.e., having two or more arylamino groups
  • polyphenols such as, for example, bisphenol A or bisphenol F can be combined with monoamines and formaldehyde to make compounds with more than one 3-substituted benzoxazine group.
  • oligomeric and/or polymeric benzoxazine resins can be made using polyphenols in combination with polyarylamines and formaldehyde.
  • 3-substituted benzoxazines are re resented by the formula
  • d represents a positive integer (e.g., 1, 2, 3, or 4)
  • Z 2 represents a d-valent organic group (e.g., -CH 2 -, -C(CH 3 ) 2 -)
  • R 1 is as previously defined.
  • the phenol may be substituted with substituents such as alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, alkoxy, alkoxyalkylene, hydroxyalkyl, hydroxyl, haloalkyl, carboxyl, halo, amino, aminoalkyl, alkylcarbonyloxy, alkyloxycarbonyl, alkylcarbonyl, alkylcarbonylamino, aminocarbonyl, alkylsulfonylamino, aminosulfonyl, sulfo, or alkylsulfonyl groups.
  • at least one of the ring positions adjacent to the phenolic hydroxyl group is unsubstituted to facilitate benzoxazine ring formation.
  • the aryl portion of the phenol may be a phenyl ring, or may be selected from naphthyl, biphenyl, phenanthryl, and anthracenyl.
  • the aryl ring of the phenol may further comprise a heteroaryl ring containing 1-3 heteroatoms such as nitrogen, oxygen, or sulfur and can contain fused rings.
  • heteroaryl are pyridyl, furanyl, pyrrolyl, thienyl, thiazolyl, oxazolyl, imidazolyl, indolyl, benzofuranyl, and benzthiazolyl.
  • Examples or mono-functional phenols include phenol, cresol, 2-bromo-4-methylphenol, 2- allyphenol, and 4-aminophenol.
  • Examples of polyphenols include phenolphthalein; biphenol; bisphenol F; 4,4'-dihydroxybenzophenone; bisphenol A; 1,8-dihydroxyanthraquinone; 1,6-dihydroxynaphthalene;
  • Aldehydes suitable for preparing 3-substituted benzoxazines include, for example, formaldehyde, paraformaldehyde, 1,3,5-trioxane, and aliphatic aldehydes (e.g., aliphatic aldehydes having from 1 to 12 carbon atoms).
  • aliphatic aldehydes include crotonaldehyde, acetaldehyde, propionaldehyde, butyraldehyde, and heptaldehyde. Combinations of aldehydes may be used.
  • Amines useful in preparing 3-substituted benzoxazines are primary arylamines. They can be substituted or unsubstituted, mono- or poly- functional (with respect to arylamino groups)
  • (hetero)hydrocarbylarylamines having at least one primary amino group (i.e., -N3 ⁇ 4) bonded to an aromatic carbon atom (i.e., a carbon atom in an aromatic ring).
  • primary amino groups that are not bonded to an aromatic carbon atom are undesirable substituents in amines used to prepare 3- substituted benzoxazines and should be excluded as they may interfere with synthesis and/or stability of the benzoxazine; however, they may be tolerable in some cases (e.g., sterically hindered primary arylamines).
  • the primary arylamines can be substituted with groups such as, for example, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl. Combinations of primary arylamines may also be used.
  • Useful arylamines include, for example, aniline, 4-methoxyaniline, and 4-methylaniline.
  • poly(arylamine) refers to organic compounds containing at least two primary amine groups directly that are bonded to respective aromatic carbon atoms.
  • useful poly(arylamines) include 4,4'-methylenedianiline, 4,4'diaminobenzophenone, bis(4-aminophenyl)sulfone, 1, 3- diaminobenzene, and 1,4-diaminobenzene.
  • Curable compositions according to the present disclosure include at least one primary amine represented by the formula
  • Z 1 is an n-valent organic radical.
  • Each of the -NH 2 groups is bonded to a tetracoordinate carbon atom, wherein n is an integer greater than or equal to 1, and wherein w/x is in a range of from 0.8 to 10; and
  • Useful monoamines include, for example, methyl-, ethylamine, propylamine, hexylamine, octylamine, dodecylamine, dimethylamine, methyl ethyl amine, and aniline.
  • diamine and “polyamine,” refer to organic compounds containing two or at least two primary amine groups, respectively.
  • Examples of useful polyamines include 3,9-bis-(3-aminopropyl)-2,4,8,10- tetraoxaspiro[5,5]undecane, and polyoxyethylenediamine, JV-methyl-l,3-propanediamine, V-ethyl- 1 ,2- ethane diamine, 2-(2-aminoethylamino)ethanol, pentaethylenehexaamine, ethylenediamine,
  • H 2 N(CH 2 ) 3 NHCH 2 CH CHCH 2 NH(CH 2 ) 3 NH. 2 , H 2 N(CH 2 ) 4 NH(CH 2 ) 3 NH 2 ,
  • Useful polyamines also include poly(alkyleneoxy)polyamines such as, for example, H 2 N-R 10 -O- (R u O) p -(R 12 0) q -(R 11 0) r -R 10 -NH 2 and [H 2 N-R 10 0-(R u O) p -] s -R 13 .
  • R 10 , R 11 and R 12 are independently alkylene groups having from 1 to 10 carbon atoms.
  • R 10 may be an alkyl group having 2 to 4 carbon atoms (e.g., ethyl, n-propyl, isopropyl, n-butyl, or isobutyl)
  • R 7 and R 8 may be alkyl groups having 2 or 3 carbon atoms (e.g., ethyl, n-propyl, or isopropyl).
  • R 9 is the residue of a polyol used to prepare the poly(alkyleneoxy)polyamines (i.e., the organic structure that remains if the hydroxyl groups are removed).
  • R 13 may be branched or linear, and substituted or unsubstituted (although substituents should not interfere with oxyalkylation reactions).
  • the quantity p represents a number greater than or equal to 1, desirably from 1 to 150, or even from 1 to 20. Structures in which p is 2, 3 or 4 may also be especially useful.
  • the quantities q and r represent numbers greater than or equal to zero.
  • the quantity s is greater than two 2, desirably 3 or 4 (so as to provide, respectively, polyoxyalkylene triamines and tetraamines).
  • p, q, r and s are chosen such that the resulting product is a liquid at room temperature as this simplifies handling and mixing thereof.
  • poly(alkyleneoxy)polyamines are liquid.
  • poly(alkyleneoxy)polyamines examples include poly(ethylene oxide) diamine, poly(propylene oxide)diamine, poly(propylene oxide)triamine, diethylene glycol propylene diamine, triethylene glycol propylene diamine, poly(tetramethyleneoxide)diamine, poly(ethylene oxide)-co-poly(propylene oxide)diamine, and poly(ethylene oxide)-co-poly(propylene oxide) triamine.
  • Suitable commercially available poly(alkyleneoxy)polyamines include those available under the trade designation JEFFAMINE from Huntsman Chemical Company (Salt Lake City Utah) such as the JEFFAMINE D, ED, and EDR series diamines (e.g., D-400, D-2000, D-5000, ED-600, ED-900, ED-2001, and EDR- 148), and the JEFFAMINE T series triamines (e.g., T-403), as well as a poly(alkyleneoxy)polyamine available as H221 from Union Carbide Company (Danbury, Connecticut).
  • Useful polyamines also include, for example, amine-terminated oligo- and poly- (diaryl)siloxanes and (dialkyl)siloxanes, amino-terminated polyethylenes or polypropylenes, and amino terminated poly(alkylene oxides).
  • Useful polyamines also include polydialkylsiloxanes with pendent or terminal amino groups.
  • Exemplary commercial polydialkylsiloxanes having terminal or pendent amine groups include those available as: PDMS DIAMINE 5k, 10k, or 15k from 3M Company ( Saint Paul, Minnesota); TEGOMER A-Si 2120 or 2130 from Th.
  • Goldschmidt (Essen, Germany); DMS-A11, A12, A15, A25, or A32, AMS-132, 152, 162, or 232, or ATM-1112 from Gelest, Inc. (Morrisville, Pennsylvania); or RHODORSIL 21643 and 21644, 21642, or 21637 from Rhodia SA (Courbevoie, France).
  • the benzoxazine and polyamine are combined in a respective equivalent ratio (w/x) in a range of from 0.8 to 10. In some embodiments, the ratio may be in a range of from 0.8 to 5, 0.8 to 4, or even 0.8 to 2, inclusive.
  • Curable compositions according to the present disclosure include a superacid.
  • Superacids are, by definition, Bronsted acids that are more acidic than 100 percent sulfuric acid. Examples include salts of a substituted pentafluoroantimonic acid having the formula
  • R 14 examples include 2-hydroxyethoxy and 2-(2'-hydroxyethoxy)ethoxy.
  • examples of commercially available superacids include trifluoromethanesulfonic acid, and those available as NACURE SUPER XC- 7231 and NACURE SUPER XC-A230, both from King Industries (Norwalk, Connecticut).
  • the superacid is generally present in an amount effective to affect the cure rate of the curable composition (i.e., an effective amount). Typically, such an effective amount is less than about 10 percent by weight, more typically less than about 5 percent by weight, or even less than about 1 percent by weight, based on the total weight of the curable composition.
  • Curable compositions according to the present disclosure can generally be prepared by simply combining the components thereof with mixing. In some cases, it may be desirable to warm one or more of the components (e.g., to melt a solid component) prior to combining. Curing of the curable composition is typically accomplished by heating using a heat source. Examples of suitable heat sources include ovens, hot platens, and infrared radiation.
  • the present disclosure provides B-stage compositions (e.g., as adhesive sheets or tapes).
  • Processing applications such as printed circuit manufacture often employ stageable adhesives (i.e., adhesive compositions which can be partially cured to a tacky or tack-free state, disposed on a substrate, and cured - typically using heat and/or pressure).
  • stageable adhesives i.e., adhesive compositions which can be partially cured to a tacky or tack-free state, disposed on a substrate, and cured - typically using heat and/or pressure.
  • the partially-cured, tack-free state is commonly referred to as the "B-stage”.
  • the physical properties (e.g., viscosity, tack, peel, shear) of uncured, B-stage, and cured compositions can be readily altered through the use of different amounts and types of each component in the curable composition.
  • the curable compositions may generally be made by mixing in any order the benzoxazine compound(s), arylamine, and superacid. Generally, the curable composition is then heated to a sufficient temperature (e.g., between about 50°C and 200°C) for a time of about 1-120 minutes, although other conditions may also be used.
  • a sufficient temperature e.g., between about 50°C and 200°C
  • Suitable heat sources include, for example induction heating coils, ovens, hot plates, heat guns, infrared sources including lasers, microwave sources.
  • Solvent can be used to assist in preparation and/or coating of the curable composition, and as a processing aid. For example, it may be advantageous to prepare a concentrated solution of the catalyst in a small amount of solvent to simplify the preparation of the polymerizable composition.
  • exemplary solvents include lactones, such as gamma-butyrolactone, gamma-valerolactone; and epsilon-caprolactone; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclopentanone and
  • sulfones such as tetramethylene sulfone, 3-methylsulfolane, 2,4-dimethylsulfolane, butadiene sulfone, methyl sulfone, ethyl sulfone, propyl sulfone, butyl sulfone, methyl vinyl sulfone, and 2,2'-sulfonyldiethanol
  • sulfoxides such as dimethyl sulfoxide
  • cyclic carbonates such as propylene carbonate, ethylene carbonate, and vinylene carbonate
  • carboxylic acid esters such as ethyl acetate, methyl cellosolve acetate, methyl formate
  • methylene chloride nitromethane, acetonitrile, glycol sulfite, and 1 ,2-dimethoxyethane (glyme).
  • Adjuvants may optionally be added to the curable composition.
  • examples include colorants, abrasive granules, anti-oxidant stabilizers, thermal degradation stabilizers, light stabilizers, conductive particles, tackifiers, fillers, flow agents, bodying agents, flatting agents, inert fillers, binders, blowing agents, fungicides, bactericides, surfactants, plasticizers, rubber tougheners and other additives known to those skilled in the art.
  • curable compositions according to the present disclosure are disposed on a liner (e.g., if formed into a thermosetting sheet or tape).
  • exemplary article 100 comprises a curable composition 1 10 according to the present disclosure disposed on first releasable liner 120.
  • curable composition 110 is sandwiched between first releasable liner 120 and optional first releasable liner 130.
  • Releasable liners are well-known in the art and include, for example, siliconized paper, and polyolefin films (e.g., polypropylene films).
  • curable composition 1 10 may, for example, be coated onto, or laminated to one or both of the releasable liners.
  • compositions according to the present disclosure are useful; for example, as coatings, foams, shaped articles, adhesives (including structural and semi-structural adhesives), magnetic media, filled or reinforced composites, coated abrasives, caulking and sealing compounds, casting and molding compounds, potting and encapsulating compounds, impregnating and coating compounds, conductive adhesives for electronics, protective coatings for electronics, and other applications that are known to those skilled in the art.
  • meta-Xylenediamine (0.68 g, 0.005 mol, obtained as MXDA from Mitsubishi Gas, Japan) and 2.31 g (0.005 mol) of finely powdered ARALDITE MT 35600 (Huntsman Corp. LLC, Salt Lake City, Utah), a Bisphenol A -based benzoxazine, were admixed and stirred at room temperature for several minutes until a uniform doughy mixture was obtained. An aliquot of the mixture was then placed into an open aluminum differential scanning calorimetry (DSC) pan and heated at 10°C/min from 25°C to 300°C in a Differential Scanning Calorimeter (Seiko Instruments USA, Inc., Torrance, California).
  • DSC differential scanning calorimetry
  • the DSC trace was recorded and is labeled "CEla” in FIG. 2. The entire procedure was repeated.
  • the DSC trace of the replicate run is labeled "CElb” in FIG. 2.
  • the different size of the area under the peak in trace CElb as compared to trace CEla is a function of DSC testing variables, principally the specimen weight, which was not controlled. This is shown here to emphasize that the important factors, in comparing cure using the traces of FIG. 2, are the overall shape of the traces and the onset temperatures for peaks, which are roughly the same for traces CEla and CElb.
  • Adipic acid (0.10 g) was added to 0.68 g (0.005m) meta-xylenediamine (MXDA). This mixture and 2.31 g (0.005m) of finely powdered ARALDITE MT 35600 Bisphenol-A based benzoxazine were admixed and stirred at room temperature for several minutes until a uniform doughy mixture was obtained. An aliquot of the mixture was then placed into an open aluminum DSC pan and heated at 10°C /min from 25°C to 300°C in a Differential Scanning Calorimeter (Seiko Instruments USA ). The DSC trace was recorded and is labeled "CE3" in FIG. 2. COMPARATIVE EXAMPLE 4 (CE4)
  • Dibutyltin dilaurate (0.10 g) was added to 0.68 g (0.005 mol) meta-xylenediamine (MXDA).
  • MXDA meta-xylenediamine
  • This mixture and 2.31 g (0.005 mol) of finely powdered ARALDITE MT 35600 Bisphenol-A based benzoxazine were admixed and stirred at room temperature for several minutes until a uniform doughy mixture was obtained. An aliquot of the mixture was then placed into an open aluminum DSC pan and heated at 10°C/min from 25°C to 300°C in a Differential Scanning Calorimeter (Seiko Instruments USA). The DSC trace was recorded and is labeled "CE4" in FIG. 2.
  • DEG-SbF5 Diethylene glycol / antimony pentafluoride (DEG-SbF5) adduct (0.10 g, prepared according to U.S. Patent No. 5,280,067 (Tarbutton et al.)), was added to 0.68 g (0.005 m) meta-xylenediamine
  • a broad exotherm was observed, having minor peaks at about 153°C and about 239°C.
  • the amount of energy released during the lower temperature exotherm was found, by integration of the peak, to be 49 Joules/gram, while the broad higher temperature peak released over two and half times as much energy, 127 J/g of the curable composition.
  • JEFFAMINE D230 polyamine (1.15 g, 0.005 mol, Huntsman Corp.) and 2.31 g (0.005 mol) of finely powdered ARALDITE MT 35600 Bisphenol-A based benzoxazine were admixed and stirred at room temperature for several minutes until a uniform doughy mixture was obtained. An aliquot of the mixture was then placed into an open aluminum DSC pan and heated at 10°C/min from 25°C to 300°C in a Differential Scanning Calorimeter (Seiko Instruments USA). The DSC trace was recorded and is labeled "CE5" in FIG. 3. COMPARATIVE EXAMPLE 6 (CE6)
  • Adipic acid (0.10 g) was added to 1.15 g (0.005m) JEFF AMINE D230 polyamine. This mixture and 2.31 g (0.005 mol) of finely powdered ARALDITE MT 35600 Bisphenol-A based benzoxazine were admixed and stirred at room temperature for several minutes until a uniform doughy mixture was obtained. An aliquot of the mixture was then placed into an open aluminum DSC pan and heated at 10°C /min from 25°C to 300°C in a Differential Scanning Calorimeter (Seiko Instruments USA). The DSC trace was recorded and is labeled "CE7" in FIG. 3.
  • NACURE SUPER XC-7231 catalyst (0.10 g), was added to 1.15 g (0.005m) JEFFAMINE D230. This mixture and 2.31 g (0.005 mol) of finely powdered ARALDITE MT 35600 Bisphenol-A based benzoxazine were admixed and stirred at room temperature for several minutes until a uniform doughy mixture was obtained. An aliquot of the mixture was then placed into an open aluminum DSC pan and heated at 10 C/min from 25 C to 300 C in a Differential Scanning Calorimeter (Seiko Instruments USA, Inc., Torrance, CA). The DSC trace was recorded and is labeled "EX3" in FIG. 3.
  • FIG. 3 Differential Scanning Calorimeter
  • Overlap (or "lap") shear specimens were made using 4" x 7" x 0.063" (10 cm x 18 cm x 0.160 cm) 7075 T6 bare aluminum that had been anodized according to Boeing Aircraft Company Specification BAC-5555.
  • the anodization voltage was 22.5 volts.
  • the specimen was generated as described in ASTM Specification D- 1002.
  • the specific thermal coating conditions varied, as described below in each Example.
  • a strip of approximately 0.5" (1.3 cm) x 0.15 mm of adhesive was applied to one edge of each of the two adherends using a scraper.
  • Three 75-micron diameter piano wires were used as spacers for bondline thickness control. The bond was closed and taped on the edge. The bond was placed between sheets of aluminum foil and pieces of cardboard.
  • Two 14# steel plates were used to apply pressure to provide for adhesive spreading. After the adhesive had been allowed to cure (as described in each Example), the large specimen was cut into 1 " (2.5 cm) wide smaller specimens, providing a 0.5 in ⁇ (3.2 crn ⁇ ) bonded area. Six lap shear specimens were obtained from each larger specimen.
  • OAKITE 165 caustic wash solution (Chemetall Americas, New Bedford, New Jersey), at a temperature of 85°C;
  • the panels were further treated as follows.
  • the etched panels were anodized by immersion in phosphoric acid at 22°C. with an applied voltage of 15 Volts for 20-25 minutes, then rinsed with tap water (and tested for water break), air dried for 10 minutes at room temperature, then oven dried in a forced air oven at 66°C for 10 minutes.
  • the resulting anodized aluminum panels were primed within
  • the anodized panels were primed with a corrosion inhibiting primer for aluminum (3M SCOTCH-WELD Structural Adhesive Primer EW-5000, available from 3M Company) according to the manufacturer's instructions to give a dried primer thickness of between 0.00010 and 0.00020 inches (2.6 to 5.2 micrometers).
  • a corrosion inhibiting primer for aluminum 3M SCOTCH-WELD Structural Adhesive Primer EW-5000, available from 3M Company
  • the primed panels were bonded together using the same film adhesive and cure cycle employed for the overlap shear samples, then evaluated for floating roller peel strength in accordance with test method ASTM D-3167-76 with the following modification. Test strips measuring
  • a curable composition comprising:
  • R 1 represents an aryl group or a substituted aryl group
  • R 2 , R 3 , R 4 , and R 5 taken alone or in combination, represent H, halogen, a hydrocarbyl group, or a heterohydrocarbyl group;
  • R 6 represents H, or a hydrocarbyl group
  • Z 1 is an n-valent organic radical, wherein each of the -NH 2 groups is bonded to a tetracoordinate carbon atom, wherein n is an integer greater than or equal to 1, and wherein w/x is in a range of from 0.8 to 10;
  • the present disclosure provides a curable composition according to the first embodiment, wherein w/x is in a range of from 0.8 to 4, inclusive.
  • the present disclosure provides a curable composition according to the first embodiment, wherein w/x is in a range of from 0.8 to 2, inclusive.
  • the present disclosure provides a curable composition according to any one of the first to third embodiments, wherein the superacid comprises antimony.
  • the present disclosure provides a curable composition according to any one of the first to fourth embodiments, wherein Z 1 is selected from the group consisting of
  • the present disclosure provides a curable composition according to any one of the first to fifth embodiments, wherein the benzoxazine is represented by the formula
  • R 2 , R 3 , R 4 , R 5 , and R 6 are as previously defined;
  • R 7 represents a divalent organic group having from 1 to 50 carbon atoms, wherein R 7 is bonded to adjacent N atoms through aromatic carbon atom to nitrogen atom bonds.
  • the present disclosure provides a curable composition according to the sixth embodiment, wherein -R 7 - is represented by the formula - Ar 1 -R8 -Ar 2 -, wherein Ar 1 and Ar2 represent substituted or unsubstituted arylene groups having from 1 to 20 carbon atoms, and R 8 represents an alkylene group having from 1 to 50 carbon atoms or a heteroalkylene group having from 1 to 50 carbon atoms.
  • the present disclosure provides a curable composition according to the sixth embodiment, wherein -R 7 - is substituted or unsubstituted arylene or substituted or unsubstituted heteroarylene.
  • the present disclosure provides a curable composition according to any one of the first to eighth embodiments, wherein the composition is B-staged.
  • reaction product of components comprising:
  • R 1 represents an aryl group or a substituted aryl group
  • R 2 , R 3 , R 4 , and R 5 taken alone or in combination, represent H, halogen, a hydrocarbyl group, or a heterohydrocarbyl group
  • R 6 represents H, or a hydrocarbyl group
  • Z 1 is an n-valent organic radical, wherein each of the -NH 2 groups is bonded to a tetraco ordinate carbon atom, wherein n is an integer greater than or equal to 1, and wherein w/x is in a range of from 0.8 to 10;
  • the present disclosure provides a method comprising at least partially a curable composition, wherein the curable composition comprises:
  • R represents an aryl group or a substituted aryl group
  • R 2 , R 3 , R 4 , and R 5 taken alone or in combination, represent H, halogen, a hydrocarbyl group, or a heterohydrocarbyl group;
  • R 6 represents H, or a hydrocarbyl group
  • Z 1 is an n-valent organic radical, wherein each of the -N3 ⁇ 4 groups is bonded to a tetracoordinate carbon atom, wherein n is an integer greater than or equal to 1, and wherein w/x is in a range of from 0.8 to 10;
  • the present disclosure provides a method according to the eleventh embodiment, wherein w/x is in a range of from 0.8 to 4, inclusive.
  • the present disclosure provides a method according to the eleventh embodiment, wherein w/x is in a range of from 0.8 to 2, inclusive. In a fourteenth embodiment, the present disclosure provides a method according to any one of the eleventh to thirteenth embodiments, wherein the superacid comprises antimony.
  • the present disclosure provides a method according to any one of the eleventh to fourteenth embodiments, wherein Z 1 is selected from the group consisting of hydrocarbylene groups having from 2 to 50 carbon atoms, and heterohydrocarbylene groups having from 4 to 50 carbon atoms.
  • the present disclosure provides a method according to any one of the eleventh to fifteenth embodiments wherein the benzoxazine is represented by the formula
  • R 2 , R 3 , R 4 , R 5 , and R 6 are as previously defined;
  • R 7 represents a divalent organic group having from 1 to 50 carbon atoms, wherein R 7 is bonded to adjacent N atoms through aromatic carbon atom to nitrogen atom bonds.
  • the present disclosure provides a method according to the sixteenth embodiment, wherein -R 7 - is represented by the formula - Ar 1 -R 8 -Ar 2 -, wherein Ar 1 and Ar 2 represent substituted or unsubstituted arylene groups having from 1 to 20 carbon atoms, and R 8 represents an alkylene group having from 1 to 50 carbon atoms or a heteroalkylene group having from 1 to 50 carbon atoms.
  • the present disclosure provides a method according to the sixteenth embodiment, wherein -R 7 - is substituted or unsubstituted arylene or substituted or unsubstituted heteroarylene.
  • the present disclosure provides a method according to any one of the eleventh to eighteenth embodiments, wherein the composition is B-staged.
  • the present disclosure provides an article comprising a curable composition disposed on a first releasable liner, wherein the curable composition comprises
  • R 1 represents an aryl group or a substituted aryl group
  • R 2 , R 3 , R 4 , and R 5 taken alone or in combination, represent H, halogen, a hydrocarbyl group, or a heterohydrocarbyl group;
  • R 6 represents H, or a hydrocarbyl group
  • Z is an n-valent organic radical, wherein each of the -NH 2 groups is bonded to a tetracoordinate carbon atom, wherein n is an integer greater than or equal to 1, and wherein w/x is in a range of from 0.8 to 10;
  • the present disclosure provides an article according to the twentieth embodiment, herein the curable composition is sandwiched between the first releasable liner and a second releasable liner.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PCT/US2012/027816 2011-03-28 2012-03-06 Curable composition, article, method of curing, and reaction product Ceased WO2012134731A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2014502591A JP5972353B2 (ja) 2011-03-28 2012-03-06 硬化性組成物、物品、硬化方法、及び反応生成物
CN201280012964.7A CN103562317A (zh) 2011-03-28 2012-03-06 可固化组合物、制品、固化方法和反应产物
US14/003,121 US20140011052A1 (en) 2011-03-28 2012-03-06 Curable composition, article, method of curing, and reaction product
EP12709760.8A EP2691466B1 (en) 2011-03-28 2012-03-06 Curable composition, article, method of curing, and reaction product
KR1020137028015A KR20140021613A (ko) 2011-03-28 2012-03-06 경화성 조성물, 물품, 경화 방법, 및 반응 생성물

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161468313P 2011-03-28 2011-03-28
US61/468,313 2011-03-28

Publications (1)

Publication Number Publication Date
WO2012134731A1 true WO2012134731A1 (en) 2012-10-04

Family

ID=45856033

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/027816 Ceased WO2012134731A1 (en) 2011-03-28 2012-03-06 Curable composition, article, method of curing, and reaction product

Country Status (6)

Country Link
US (1) US20140011052A1 (enExample)
EP (1) EP2691466B1 (enExample)
JP (1) JP5972353B2 (enExample)
KR (1) KR20140021613A (enExample)
CN (1) CN103562317A (enExample)
WO (1) WO2012134731A1 (enExample)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9156946B2 (en) 2011-09-28 2015-10-13 3M Innovative Properties Company Amine/thiol curing of benzoxazines
US9169393B2 (en) 2013-07-25 2015-10-27 3M Innovative Properties Company Anticorrosion coatings
US9228112B2 (en) 2012-02-10 2016-01-05 3M Innovative Properties Company Anticorrosion coatings
US9371477B2 (en) 2012-12-27 2016-06-21 3M Innovative Properties Company Polymerizable composition including a benzoxazine and an acid-forming peroxide catalyst, article, and method
US9416302B2 (en) 2012-09-28 2016-08-16 3M Innovative Properties Company Polybenzoxazine composition
US9611360B2 (en) 2011-03-28 2017-04-04 3M Innovative Properties Company Curable composition, article, method of curing, and tack-free reaction product
WO2017196805A1 (en) 2016-05-10 2017-11-16 Huntsman Advanced Materials Americas Llc Benzothiazoles as latent catalysts for benzoxazine resins
US9896599B2 (en) 2013-04-30 2018-02-20 3M Innovative Properties Company Process for preparing poly(benzoxazines)
US10040905B2 (en) 2013-10-16 2018-08-07 3M Innovative Properties Company Benzoxazine polymerization
US10731003B2 (en) 2016-09-15 2020-08-04 3M Innovative Properties Company Benzoxazine composition
US10882955B2 (en) 2015-06-09 2021-01-05 3M Innovative Properties Company Ammonium salt catalyzed benzoxazine polymerization
WO2022069947A1 (en) * 2020-09-29 2022-04-07 Kaneka Corporation Synthesis of self-healing benzoxazine polymers through melt polymerization

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104024331B (zh) 2011-10-28 2016-10-19 3M创新有限公司 苯并噁嗪的胺/环氧树脂固化
JP2017538836A (ja) 2014-12-18 2017-12-28 スリーエム イノベイティブ プロパティズ カンパニー 改善された熱安定性を有する硬化性ベンゾオキサジン組成物
US11124608B2 (en) * 2018-04-04 2021-09-21 Case Western Reserve University Polybenzoxazine resins with high hydrogen content, and composites therefrom
TWI756020B (zh) * 2021-01-13 2022-02-21 南亞塑膠工業股份有限公司 苯並噁嗪樹脂及其製法以及樹脂組合物
CN112828779A (zh) * 2021-01-21 2021-05-25 上海橄榄精密工具有限公司 一种铝基砂轮的制备方法及砂轮

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501864A (en) 1983-12-22 1985-02-26 Monsanto Company Polymerizable compositions comprising polyamines and poly(dihydrobenzoxazines)
US4507428A (en) * 1984-02-17 1985-03-26 Monsanto Company Aqueous dispersions of polyamines and poly(dihydrobenzoxazines)
US5280067A (en) 1992-06-18 1994-01-18 Minnesota Mining And Manufacturing Company Substituted pentafluoroantmonic acid-substituted aniline epoxy curing catalysts
US5543516A (en) 1994-05-18 1996-08-06 Edison Polymer Innovation Corporation Process for preparation of benzoxazine compounds in solventless systems
US7041772B2 (en) 2001-03-12 2006-05-09 Hitachi Chemical Co., Ltd. Method for producing benzoxazine resin
WO2008095850A1 (en) 2007-02-08 2008-08-14 Huntsman Advanced Materials (Switzerland) Gmbh Thermosetting composition
WO2008095837A1 (en) * 2007-02-08 2008-08-14 Huntsman Advanced Materials (Switzerland) Gmbh Thermosetting composition
WO2011025652A1 (en) * 2009-08-26 2011-03-03 3M Innovative Properties Company Polybenzoxazine composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503211A (en) * 1984-05-31 1985-03-05 Minnesota Mining And Manufacturing Co. Epoxy resin curing agent, process and composition
JPH09504820A (ja) * 1993-11-05 1997-05-13 ミネソタ マイニング アンド マニュファクチャリング カンパニー 防食接着剤組成物及びその製造方法
US6207786B1 (en) * 1998-11-10 2001-03-27 Edison Polymer Innovation Corporation Ternary systems of benzoxazine, epoxy, and phenolic resins
US6326072B1 (en) * 1999-01-29 2001-12-04 3M Innovative Properties Company Release liner incorporating syndiotactic vinyl aromatic polymer
EP1647576A1 (en) * 2005-04-01 2006-04-19 Huntsman Advanced Materials (Switzerland) GmbH Composition comprising benzoxazine and epoxy resin
KR20140058557A (ko) * 2011-07-15 2014-05-14 쓰리엠 이노베이티브 프로퍼티즈 컴파니 반도체 패키지 수지 조성물 및 그의 사용 방법

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501864A (en) 1983-12-22 1985-02-26 Monsanto Company Polymerizable compositions comprising polyamines and poly(dihydrobenzoxazines)
US4507428A (en) * 1984-02-17 1985-03-26 Monsanto Company Aqueous dispersions of polyamines and poly(dihydrobenzoxazines)
US5280067A (en) 1992-06-18 1994-01-18 Minnesota Mining And Manufacturing Company Substituted pentafluoroantmonic acid-substituted aniline epoxy curing catalysts
US5543516A (en) 1994-05-18 1996-08-06 Edison Polymer Innovation Corporation Process for preparation of benzoxazine compounds in solventless systems
US7041772B2 (en) 2001-03-12 2006-05-09 Hitachi Chemical Co., Ltd. Method for producing benzoxazine resin
WO2008095850A1 (en) 2007-02-08 2008-08-14 Huntsman Advanced Materials (Switzerland) Gmbh Thermosetting composition
WO2008095837A1 (en) * 2007-02-08 2008-08-14 Huntsman Advanced Materials (Switzerland) Gmbh Thermosetting composition
WO2011025652A1 (en) * 2009-08-26 2011-03-03 3M Innovative Properties Company Polybenzoxazine composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
N. N. GHOSH ET AL.: "Polybenzoxazine-new high performance thermosetting resins: synthesis and properties", PROG. POLYM. SCI., vol. 32, 2007, pages 1344 - 1391, XP002681429, DOI: doi:10.1016/J.PROGPOLYMSCI.2007.07.002

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9611360B2 (en) 2011-03-28 2017-04-04 3M Innovative Properties Company Curable composition, article, method of curing, and tack-free reaction product
US9156946B2 (en) 2011-09-28 2015-10-13 3M Innovative Properties Company Amine/thiol curing of benzoxazines
US9228112B2 (en) 2012-02-10 2016-01-05 3M Innovative Properties Company Anticorrosion coatings
US9416302B2 (en) 2012-09-28 2016-08-16 3M Innovative Properties Company Polybenzoxazine composition
US9371477B2 (en) 2012-12-27 2016-06-21 3M Innovative Properties Company Polymerizable composition including a benzoxazine and an acid-forming peroxide catalyst, article, and method
US9896599B2 (en) 2013-04-30 2018-02-20 3M Innovative Properties Company Process for preparing poly(benzoxazines)
US9169393B2 (en) 2013-07-25 2015-10-27 3M Innovative Properties Company Anticorrosion coatings
US10040905B2 (en) 2013-10-16 2018-08-07 3M Innovative Properties Company Benzoxazine polymerization
US10882955B2 (en) 2015-06-09 2021-01-05 3M Innovative Properties Company Ammonium salt catalyzed benzoxazine polymerization
WO2017196805A1 (en) 2016-05-10 2017-11-16 Huntsman Advanced Materials Americas Llc Benzothiazoles as latent catalysts for benzoxazine resins
US10889686B2 (en) 2016-05-10 2021-01-12 Huntsman Advanced Materials Americas Llc Benzothiazoles as latent catalysts for benzoxazine resins
US10731003B2 (en) 2016-09-15 2020-08-04 3M Innovative Properties Company Benzoxazine composition
WO2022069947A1 (en) * 2020-09-29 2022-04-07 Kaneka Corporation Synthesis of self-healing benzoxazine polymers through melt polymerization
JP2023543292A (ja) * 2020-09-29 2023-10-13 株式会社カネカ 溶融重合による自己修復性ベンゾオキサジンポリマーの合成
JP7631515B2 (ja) 2020-09-29 2025-02-18 株式会社カネカ 溶融重合による自己修復性ベンゾオキサジンポリマーの合成

Also Published As

Publication number Publication date
EP2691466B1 (en) 2017-12-27
JP2014509678A (ja) 2014-04-21
CN103562317A (zh) 2014-02-05
JP5972353B2 (ja) 2016-08-17
KR20140021613A (ko) 2014-02-20
EP2691466A1 (en) 2014-02-05
US20140011052A1 (en) 2014-01-09

Similar Documents

Publication Publication Date Title
EP2691466B1 (en) Curable composition, article, method of curing, and reaction product
JP6306131B2 (ja) 硬化性組成物、物品、硬化方法及びタックフリー反応生成物
JP6279588B2 (ja) ポリベンゾオキサジン組成物
EP2760914B1 (en) Amine and thiol curing of benzoxazines
EP2771402B1 (en) Amine/epoxy curing of benzoxazines
JP5781074B2 (ja) ポリベンゾキサジン組成物
KR101879001B1 (ko) 벤족사진-티올 중합체 필름의 제조 방법

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12709760

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 14003121

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2012709760

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2014502591

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20137028015

Country of ref document: KR

Kind code of ref document: A